Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 3, 2002 - Issue 1
Submit an article Journal homepage
52
Views
3
CrossRef citations to date
0
Altmetric
Review

The role of leukotriene inhibitors in allergic rhinitis and paranasal sinusitis

Steven M Parnes Department of Surgery, Division of Otolaryngology, Albany Medical College, 47 New Scotland Avenue, MC-41, Albany, New York 12208, USA. [email protected]
Pages 33-38 | Published online: 25 Feb 2005

REFERENCES

  • DRAZEN JM, ISRAEL E, O'BYRNE P: Treatment of asthma with drugs modifying the leukotriene pathway. N Engl. I Med. (1999) 340:197–206.
  • BUSSE WW, MCGILL KA, HORWITZ RJ: Leukotriene pathway inhibitors in asthma and chronic obstructive pulmonary disease. Chu. Esp. Allergy (1999) 29(S2):S110–115.
  • O'BYRNE PM: Leukotrienes in the pathogenesis of asthma. Chest (1997) 111(S2):S27–S34.
  • FERRERI N, HOWLAND WC, STEVENSON DD, SPIELBERG HL: Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin. Amu. Rev. Resp. Dis. (1988) 137:847–854.
  • O'BYRNE PM, ISRAEL E, DRAZEN JM: Antileukotrienes in the treatment of asthma. Ann. Int. Med. (1997) 127(6):472–480.
  • TAN RA: The role of antileukotrienes in asthma management. Curr. Opiri. Pulm. Med. (1998) 4(1):25–30.
  • DRAZEN J: Clinical pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors. Am. I Respir. Crit. Care Med. (1998) 157:S233–237.
  • BARNES NC, DEJONG B, MIYAMOTO T: Worldwide clinical experience with the first marketed leukotriene receptor antagonist. Chest (1997) 111(52):552–560.
  • MALMSTROM K, RODRIGUEZ-GOMEZ G, GUERRA J et al: Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. Ann. Irm Med. (1999) 130(6):487–495.
  • NATHAN RA: Anti-leukotriene agents: a new direction in asthma therapy. I Asthma (1996) 33(6):353–366.
  • DIAMANT Z, BEL EH, DEKHUIJZEN PN: Anti-leukotriene therapy in asthma. Netherland s J Med. (1998) 53(4):176–189.
  • MISSON J, CLARK W, KENDALL MJ: Therapeutic advances: leukotriene antagonists for the treatment of asthma. Chu. Pharm. (1999) 24(1):17–22.
  • KNORR B, MATZ J, BERNSTEIN JA et al.: Montelukast for chronic asthma in 6-and 14-year old children: a randomized, double-blind trial. JAMA (1998) 279(15):1181–1186.
  • NACLERIO RM, BAROODY FM, TOGIAS AG: The role of leukotrienes in allergic rhinitis: a review. j Rev Respir. Dis. (1991) 143:S91–S95.
  • FLOWERS BK, PROUD D, KAGEY-SOBOTKA A, LICHTENSTEIN LM, NACLERIO RM: The effect of a leukotriene antagonist on the early response to antigen. Oto. Head Neck Surg. (1990) 102(3):219–224.
  • KNAPP HR: Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. N Engl. j Med. (1990) 323(25):1745–1748.
  • DONNELLY AL, GLASS M, MINKWITZ MC, CASALE TB: The leukotriene D4-receptor antagonist, ICI 204219, relieves symptoms of acute seasonal allergic rhinitis. Am. I Respir. Grit. Care Med. (1995) 151:1734–1739.
  • DAHLEN B: Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am. j Respir. Care Med. (1998) 157:1187–1194.
  • LAROCCA LM, MAGGIANO N, CAPELI A et al.: Immunopathology of nasal polyps: an immunohistochemical approach. Ann. Allergy (1989) 63:508–51.
  • JUNG TTK, JUHN SK, HWANG D, STEWART R: Prostaglandins, leukotrienes, and other arachidonic acid metabolites in nasal polyps and nasal mucosa. Laryngoscope (1987) 97:184–188.
  • PINTO S, GALLO 0, POLLI G et al: Cyclooxygenase and lipoxygenase metabolite generation in nasal polyps. Frost. Leuk. Es. Fat. Ac. (1997) 6:533–537.
  • KLAPAN I, CULO F, CULIG J et al: Arachidonic acid metabolites and sinonasal polyposis. i. possible prognostic value. Am. Otolaryrigol (1995) 16(6):396–402.
  • BAENKLER HW, SCHAFER D, HOSEMANN W: Eicosanoids from biopsy of normal and polypous nasal mucosa. Rhiriology (1996) 34(3):166–170.
  • PICADO C, FERNANDEZ-MORATA JC, JUAN M et al: Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am. Respir Care Med. (1999) 160:291–296.
  • ULUALP SO, STERMAN BM, TOOHILL RJ: Antileukotriene therapy for the relief of sinus symptoms in aspirin triad disease. Am. Rhin. Soc. Spring Meeting, Palm Beach, FL, USA (1998). Ear Nose Throat J. (1999) 72:604–616.
  • PARNES SM, CHUMA AV: Acute effects of antileukotrienes on sinusitis and sinonasal polyposis. Ear Nose Throat J. (1999) 79:18-20,24,25.
  • CRAMPETTE L, MAINPRICE B, BLOOM M, BOUSQUET J, CAMPBELL AM: Inhibition of mediator and cytokine release from dispersed nasal polyp cells by terfenadine. Allergy (1996) 51(5):346–349.
  • GOSEPATH J, HOFMANN F, SCHAFER D, AMEDEE RG, MANN WJ: Aspirin intolerance in patients with chronic sinusitis. ORL j Oterbinelegel Relat. Spec. (1999) 61(3):146–150.
  • TOOHILL RJ: Antileukotriene therapy for the relief of sinus symptoms in aspirin triad disease. Am. Rhin. Sec. Spring Meeting, Palm Beach, FL, USA (1998).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.